WallStreetZenWallStreetZen

NASDAQ: EIGR
Eiger Biopharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their EIGR stock forecasts and price targets.

Forecast return on equity

Is EIGR forecast to generate an efficient return?

Forecast return on assets

Is EIGR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EIGR revenue growth forecast

How is EIGR forecast to perform vs Biotechnology companies and vs the US market?
Company
184.61%
Industry
39.22%
Market
10.52%
EIGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EIGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EIGR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EIGR$5.01N/AN/A
XRTX$3.70$14.00+278.38%Strong Buy
ENVB$1.00$10.00+900.00%Buy
KTTA$7.25N/AN/A
LIXT$3.38N/AN/A

Eiger Biopharmaceuticals Stock Forecast FAQ

What is EIGR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EIGR) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Eiger Biopharmaceuticals stock.

What is EIGR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EIGR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.